JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB3581

Anti-Glucocorticoid Receptor beta antibody

Be the first to review this product! Submit a review

|

(16 Publications)

Rabbit Polyclonal Glucocorticoid Receptor antibody. Suitable for WB and reacts with Transfected cell lysate - Human samples. Cited in 16 publications. Immunogen corresponding to Synthetic Peptide within Human NR3C1 aa 700-750.

View Alternative Names

GRL, NR3C1, Glucocorticoid receptor, GR, Nuclear receptor subfamily 3 group C member 1

2 Images
Western blot - Anti-Glucocorticoid Receptor beta antibody (AB3581)
  • WB

Supplier Data

Western blot - Anti-Glucocorticoid Receptor beta antibody (AB3581)

All lanes:

Western blot - Anti-Glucocorticoid Receptor beta antibody (ab3581)

All lanes:

hGR beta transfected COS-7 whole cell extract

Predicted band size: 85 kDa

false

Western blot - Anti-Glucocorticoid Receptor beta antibody (AB3581)
  • WB

Unknown

Western blot - Anti-Glucocorticoid Receptor beta antibody (AB3581)

All lanes:

Western blot - Anti-Glucocorticoid Receptor beta antibody (ab3581) at 1/500 dilution

Lane 1:

COS-74 whole cell extract transfected with Glucocorticoid Receptor alpha

Lane 2:

COS-74 whole cell extract transfected with Glucocorticoid Receptor beta

Predicted band size: 85 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human NR3C1 aa 700-750. The exact immunogen used to generate this antibody is proprietary information.

P04150

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Transfected cell lysate - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p>Sample preparation: Lysates boiled in reducing buffer for 5 min. 20µg of protein loadedBlocking agent: 5% non-fat milk in Tris buffered saline (TBS) Primary antibody: overnight at 4°C</p>" } } }

Properties and storage information

Form
Liquid
Purity
Whole antiserum
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glucocorticoid Receptor beta (GRβ) also known as NR3C1 isoform β is a variant of the glucocorticoid receptor. Unlike its counterpart GRα GRβ does not bind glucocorticoids due to differences in its ligand-binding domain. With an approximate mass of 90 kDa GRβ acts primarily as a dominant negative regulator of GRα. It is expressed in various tissues including skin lung and immune cells which suggests it has a wide-reaching influence on cellular responses to glucocorticoids.
Biological function summary

GRβ functions as a modulator of glucocorticoid signaling by inhibiting the activity of GRα. Though it does not bind glucocorticoids itself it can still form part of a receptor complex that affects transcriptional activities. By reducing GRα-mediated gene expression GRβ influences the body's response to stress and inflammation. Its role as a competitor to GRα shapes the regulation of genes involved in metabolism immune function and cellular growth.

Pathways

The regulatory role of GRβ in glucocorticoid signaling impacts the hypothalamic-pituitary-adrenal (HPA) axis which is important for stress response and homeostasis. GRβ interacts with proteins involved in the NF-kB pathway connecting it to the regulation of immune and inflammatory responses. Through its effect on these pathways GRβ exerts control over the transcriptional regulation shared with GRα and other transcription factors influencing cellular processes like apoptosis and autophagy.

Alterations in GRβ expression or function link to conditions such as corticosteroid resistance and autoimmune diseases including rheumatoid arthritis. GRβ's interaction with GRα is significant because imbalances in their ratios can alter the usual glucocorticoid effects contributing to disease pathology. GRβ also connects to proteins in inflammatory signaling cascades making it an important player in understanding the molecular mechanisms underlying resistance and sensitivity to glucocorticoid therapy.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for glucocorticoids (GC) (PubMed : 27120390, PubMed : 37478846). Has a dual mode of action : as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors (PubMed : 28139699). Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed : 9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay (PubMed : 25775514). Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity).. Isoform Alpha. Has transcriptional activation and repression activity (PubMed : 11435610, PubMed : 15769988, PubMed : 15866175, PubMed : 17635946, PubMed : 19141540, PubMed : 19248771, PubMed : 20484466, PubMed : 21664385, PubMed : 23820903). Mediates glucocorticoid-induced apoptosis (PubMed : 23303127). Promotes accurate chromosome segregation during mitosis (PubMed : 25847991). May act as a tumor suppressor (PubMed : 25847991). May play a negative role in adipogenesis through the regulation of lipolytic and antilipogenic gene expression (By similarity).. Isoform Beta. Acts as a dominant negative inhibitor of isoform Alpha (PubMed : 20484466, PubMed : 7769088, PubMed : 8621628). Has intrinsic transcriptional activity independent of isoform Alpha when both isoforms are coexpressed (PubMed : 19248771, PubMed : 26711253). Loses this transcription modulator function on its own (PubMed : 20484466). Has no hormone-binding activity (PubMed : 8621628). May play a role in controlling glucose metabolism by maintaining insulin sensitivity (By similarity). Reduces hepatic gluconeogenesis through down-regulation of PEPCK in an isoform Alpha-dependent manner (PubMed : 26711253). Directly regulates STAT1 expression in isoform Alpha-independent manner (PubMed : 26711253).. Isoform Alpha-2. Has lower transcriptional activation activity than isoform Alpha. Exerts a dominant negative effect on isoform Alpha trans-repression mechanism (PubMed : 20484466).. Isoform GR-P. Increases activity of isoform Alpha.. Isoform Alpha-B. More effective than isoform Alpha in transcriptional activation, but not repression activity.. Isoform 10. Has transcriptional activation activity.. Isoform Alpha-C1. Has transcriptional activation activity.. Isoform Alpha-C2. Has transcriptional activation activity.. Isoform Alpha-C3. Has highest transcriptional activation activity of all isoforms created by alternative initiation (PubMed : 15866175, PubMed : 23820903). Has transcriptional repression activity (PubMed : 23303127). Mediates glucocorticoid-induced apoptosis (PubMed : 23303127, PubMed : 23820903).. Isoform Alpha-D1. Has transcriptional activation activity.. Isoform Alpha-D2. Has transcriptional activation activity.. Isoform Alpha-D3. Has lowest transcriptional activation activity of all isoforms created by alternative initiation (PubMed : 15866175, PubMed : 23820903). Has transcriptional repression activity (PubMed : 23303127).
See full target information NR3C1

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

International archives of allergy and immunology 184:634-642 PubMed36996773

2023

Novel Classification System of Adenoids Based on Appearance and Its Relationship with Drug Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Huan-Huan Chang,Xin-Yi Zhang,Lu An,Pan-Hong Dang,Juan Luo,Jie Wang

Frontiers in immunology 13:905727 PubMed35865549

2022

Increased Interleukin-17 and Glucocorticoid Receptor-β Expression in Interstitial Lung Diseases and Corticosteroid Insensitivity.

Applications

Unspecified application

Species

Unspecified reactive species

Chun-Yu Lo,Chun-Hua Wang,Chih-Wei Wang,Chih-Jung Chen,Hung-Yu Huang,Fu-Tsai Chung,Yu-Chen Huang,Chang-Wei Lin,Chung-Shu Lee,Chun-Yu Lin,Chiung-Hung Lin,Po-Jui Chang,Ting-Yu Lin,Chih-Chen Heh,Jung-Ru He,Kian Fan Chung

Placenta 108:64-72 PubMed33819863

2021

A preferential switch between placental GR exon 1 promoter variants in the presence of maternal asthma or inflammation upregulates GRα D isoforms.

Applications

Unspecified application

Species

Unspecified reactive species

Zarqa Saif,Ashley S Meakin,Vicki L Clifton

Skin pharmacology and physiology 34:30-37 PubMed33592607

2021

Glucocorticoid Receptor Beta and Its Prognostic Value on Treatment Response in Chronic Vulvar Dermatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Valerie Bernays,Mariusz Pawel Kowalewski,Ioannis Dedes,Katrin Kerl French,Daniel Fink,Isabel Kolm,Cornelia Betschart

Journal of cutaneous pathology 48:669-673 PubMed33368548

2021

Lichen aureus with pseudolymphomatous infiltrate.

Applications

Unspecified application

Species

Unspecified reactive species

Isabel Kolm,Caroline Buset,Ursula Flury,Daniel Nosek,Dmitry V Kazakov,Werner Kempf

Journal of cellular and molecular medicine : PubMed33094923

2020

Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Zhongkun Wang,Ge Zheng,Guangjian Li,Mengkun Wang,Zhanchuan Ma,Huimin Li,Xiang-Yang Wang,Huanfa Yi

Medical science monitor : international medical jo 26:e921649 PubMed32065117

2020

Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α.

Applications

Unspecified application

Species

Unspecified reactive species

Wenfu Xu,Zhujun Wang,Kun Li,Runming Jin

Clinical and experimental otorhinolaryngology 12:367-375 PubMed30993958

2019

Response of Glucocorticoid Receptor Alpha and Histone Deacetylase 2 to Glucocorticoid Treatment Predicts the Prognosis of Sudden Sensorineural Hearing Loss.

Applications

Unspecified application

Species

Unspecified reactive species

Xiuling Zhang,Jinxiang Chen,Ziwen Gao,Hui Qi,Yanhong Dai,Wandong She

Life sciences 221:168-177 PubMed30738043

2019

Mucin 1 downregulation impairs the anti-necroptotic effects of glucocorticoids in human bronchial epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Huojun Zhang,Qian Liu,Luxia Kong,Shuyun Xu

American journal of physiology. Lung cellular and molecular physiology 316:L71-L81 PubMed30335498

2018

Th1 cytokines TNF-α and IFN-γ promote corticosteroid resistance in developing human airway smooth muscle.

Applications

Unspecified application

Species

Unspecified reactive species

Rodney D Britt,Michael A Thompson,Sarah Sasse,Christina M Pabelick,Anthony N Gerber,Y S Prakash
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com